Wegovy is indicated for patients with obesity or who are overweight with at least one weight-related comorbidity, such as high blood pressure or high cholesterol.[1] Body mass index (BMI) is used to determine eligibility for Wegovy.[1] Patients with the following BMIs may be eligible: BMI of 30 kg/m2 or greater (obesity) BMI of 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition, such as hypertension, T2D, or dyslipidemia Semaglutide for type 2 diabetes Ozempic and Rybelsus both contain semaglutide and are used to help patients with T2D manage blood sugar levels.[2,3] Ozempic is a once-weekly subcutaneous injection.[2] It is used alongside diet and exercise to improve glycemic control and reduce the risk of major cardiovascular events, such as heart attack, in adults with T2D and established cardiovascular disease.[2] Ozempic is also sometimes prescribed off-label for weight management.[9] Because Ozempic delays gastric emptying, it can affect the absorption of oral medications.[1] It is important to tell your healthcare provider about any prescription medications, over-the-counter medications, or supplements you are taking

Our weight loss program in Georgetown, Texas employs weight loss experts who understand that each patient's body reacts differently to medications, and what works well for one person may not be suitable for another
What makes NOCO Healthcare different for medical weight loss
Electrolyte drinks with potassium and magnesium can help
bmj, 372
How to Use For professional use only Administered under clinical supervision Dosage depends on individual goals and professional advice Best results when combined with diet and exercise Storage Instructions Store in a cool, dry place Keep away from direct sunlight and heat exposure Do not freeze Keep out of reach of children Ensure proper handling in clinical environments Usage: Weight loss and body sculpting support Not Suitable For Breast feeder